Join
Live feed
·
PRReleasevia Quantisnow
IN8bio Inc. logo

IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025

ByQuantisnow·Wall Street's wire, on your screen.
INAB· IN8bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INAB (IN8bio Inc.) and more on Quantisnow.